Acute myeloid leukemia (AML) is a malignancy of stem cells with an unlimited capacity for self-renewal. MUC1 is a secreted, oncogenic mucin that is expressed aberrantly in AML blasts, but its potential uses to target AML stem cells have not been explored. Here, we report that MUC1 is highly expressed on AML CD34+/lineage-/ CD38- cells as compared with their normal stem cell counterparts. MUC1 expression was not restricted to AML CD34+ populations as similar results were obtained with leukemic cells from patients with CD34- disease. Engraftment of AML stem cell populations that highly express MUC1 (MUC1high) led to development of leukemia in NOD-SCID IL2Rgammanull (NSG) immunodeficient mice. In contrast, MUC1low cell populations established normal hematopoiesis in the NSG model. Functional blockade of the oncogenic MUC1-C subunit with the peptide inhibitor GO-203 depleted established AML in vivo, but did not affect engraftment of normal hematopoietic cells. Our results establish that MUC1 is highly expressed in AML stem cells and they define the MUC1-C subunit as a valid target for their therapeutic eradication. ©2013 AACR.

MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells / Stroopinsky, D.; Rosenblatt, J.; Ito, K.; Mills, H.; Yin, L.; Rajabi, H.; Vasir, B.; Kufe, T.; Luptakova, K.; Arnason, J.; Nardella, Caterina; Levine, J. D.; Joyce, R. M.; Galinsky, I.; Reiter, Y.; Stone, R. M.; Pandolfi, P. P.; Kufe, D.; Avigan, D.. - In: CANCER RESEARCH. - ISSN 0008-5472. - 73:17(2013), pp. 5569-5579. [10.1158/0008-5472.CAN-13-0677]

MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells

Nardella, Caterina;
2013

Abstract

Acute myeloid leukemia (AML) is a malignancy of stem cells with an unlimited capacity for self-renewal. MUC1 is a secreted, oncogenic mucin that is expressed aberrantly in AML blasts, but its potential uses to target AML stem cells have not been explored. Here, we report that MUC1 is highly expressed on AML CD34+/lineage-/ CD38- cells as compared with their normal stem cell counterparts. MUC1 expression was not restricted to AML CD34+ populations as similar results were obtained with leukemic cells from patients with CD34- disease. Engraftment of AML stem cell populations that highly express MUC1 (MUC1high) led to development of leukemia in NOD-SCID IL2Rgammanull (NSG) immunodeficient mice. In contrast, MUC1low cell populations established normal hematopoiesis in the NSG model. Functional blockade of the oncogenic MUC1-C subunit with the peptide inhibitor GO-203 depleted established AML in vivo, but did not affect engraftment of normal hematopoietic cells. Our results establish that MUC1 is highly expressed in AML stem cells and they define the MUC1-C subunit as a valid target for their therapeutic eradication. ©2013 AACR.
17
Stroopinsky, D.; Rosenblatt, J.; Ito, K.; Mills, H.; Yin, L.; Rajabi, H.; Vasir, B.; Kufe, T.; Luptakova, K.; Arnason, J.; Nardella, Caterina; Levine, J. D.; Joyce, R. M.; Galinsky, I.; Reiter, Y.; Stone, R. M.; Pandolfi, P. P.; Kufe, D.; Avigan, D.
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells / Stroopinsky, D.; Rosenblatt, J.; Ito, K.; Mills, H.; Yin, L.; Rajabi, H.; Vasir, B.; Kufe, T.; Luptakova, K.; Arnason, J.; Nardella, Caterina; Levine, J. D.; Joyce, R. M.; Galinsky, I.; Reiter, Y.; Stone, R. M.; Pandolfi, P. P.; Kufe, D.; Avigan, D.. - In: CANCER RESEARCH. - ISSN 0008-5472. - 73:17(2013), pp. 5569-5579. [10.1158/0008-5472.CAN-13-0677]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11572/251833
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 42
  • ???jsp.display-item.citation.isi??? ND
social impact